| 注册
首页|期刊导航|中国免疫学杂志|血清细胞因子IL-17与脱髓鞘性神经病多发性硬化相关性的研究:Meta分析

血清细胞因子IL-17与脱髓鞘性神经病多发性硬化相关性的研究:Meta分析

马金昀 张若曦 程晓东

中国免疫学杂志2017,Vol.33Issue(12):1832-1837,6.
中国免疫学杂志2017,Vol.33Issue(12):1832-1837,6.DOI:10.3969/j.issn.1000-484X.2017.12.016

血清细胞因子IL-17与脱髓鞘性神经病多发性硬化相关性的研究:Meta分析

Correlation between serum cytokine IL-17 and demyelinating neuropathy multiple sclerosis:a Meta-analysis

马金昀 1张若曦 2程晓东1

作者信息

  • 1. 上海中医药大学附属岳阳中西医结合医院临床免疫研究所,上海 200437
  • 2. 上海中医药大学附属岳阳中西医结合医院药学研究室,上海 200437
  • 折叠

摘要

Abstract

Objective:To evaluate the association with serum Interleukin-17 ( IL-17 ) and multiple sclerosis ( MS ) systematically evaluated .Methods:The retrieval words of "multiple sclerosis or MS"and "interleukin-17 or IL-17"were searched in PubMed,SpringerLink,Embases,OVID,China National Knowledge infrastructure (CNKI),Chinese VIP database,Chinese Biomedical Literature Database (CBM),Wan Fang Database through computer.Review Manager 5.3.was selected as the software edition.The time frame was ranged from January 1,2000 to March 10,2017.The language was not restricted .Results: Eventually 8 case-control studies were included with 544 cases.We found that the serum IL-17 level was associated with MS according to the weighted mean difference and 95%confidence interval ( WMD =38.65;95%CI:18.66 ,58.63 ) ,which had significant difference in statistics .Conclusion:The serum IL-17 level increases the risk of MS , suggesting that the serum IL-17 level can be used as a predictive biomarker for MS development and a target for MS effective prevention and treatment .

关键词

白细胞介素17/脱髓鞘/中枢神经系统/多发性硬化/Meta分析

Key words

Interleukin-17/Demyelination/Central nervous system/Multiple sclerosis/Meta-analysis

分类

医药卫生

引用本文复制引用

马金昀,张若曦,程晓东..血清细胞因子IL-17与脱髓鞘性神经病多发性硬化相关性的研究:Meta分析[J].中国免疫学杂志,2017,33(12):1832-1837,6.

基金项目

本文受国家自然科学基金面上项目(No.81173630,No.81673669)和上海中医药大学中医学高峰学科建设项目(No.30304114323)资助. (No.81173630,No.81673669)

中国免疫学杂志

OA北大核心CSCDCSTPCD

1000-484X

访问量0
|
下载量0
段落导航相关论文